These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21920590)

  • 21. Influence of methylenetetrahydrofolate reductase gene polymorphisms on homocysteine concentrations after nitrous oxide anesthesia.
    Nagele P; Zeugswetter B; Wiener C; Burger H; Hüpfl M; Mittlböck M; Födinger M
    Anesthesiology; 2008 Jul; 109(1):36-43. PubMed ID: 18580170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of folinic acid on methylenetetrahydrofolate reductase polymorphisms in methotrexate-treated allogeneic hematopoietic stem cell transplants.
    Murphy NM; Diviney M; Szer J; Bardy P; Grigg A; Hoyt R; King-Kallimanis B; Holdsworth R; McCluskey J; Tait BD
    Biol Blood Marrow Transplant; 2012 May; 18(5):722-30. PubMed ID: 21920473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of total plasma homocysteine with methylenetetrahydrofolate reductase genotypes 677C>T, 1298A>C, and 1793G>A and the corresponding haplotypes in Swedish children and adolescents.
    Böttiger AK; Hurtig-Wennlöf A; Sjöström M; Yngve A; Nilsson TK
    Int J Mol Med; 2007 Apr; 19(4):659-65. PubMed ID: 17334642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 677C>T and 1298A>C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritis.
    Kurzawski M; Pawlik A; Safranow K; Herczynska M; Drozdzik M
    Pharmacogenomics; 2007 Nov; 8(11):1551-9. PubMed ID: 18034620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The WHO score predicts treatment outcome in low risk gestational trophoblastic neoplasia patients treated with weekly intramuscular methotrexate.
    Gilani MM; Fariba B; Behtash N; Ghaemmaghami F; Moosavi AS; Rezayof E
    J Cancer Res Ther; 2013; 9(1):38-43. PubMed ID: 23575072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia.
    Aplenc R; Thompson J; Han P; La M; Zhao H; Lange B; Rebbeck T
    Cancer Res; 2005 Mar; 65(6):2482-7. PubMed ID: 15781665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylenetetrahydrofolate reductase (MTHFR) variants and bladder cancer: a population-based case-control study.
    Karagas MR; Park S; Nelson HH; Andrew AS; Mott L; Schned A; Kelsey KT
    Int J Hyg Environ Health; 2005; 208(5):321-7. PubMed ID: 16217917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MTHFR polymorphisms and 5-FU-based adjuvant chemotherapy in colorectal cancer.
    Afzal S; Jensen SA; Vainer B; Vogel U; Matsen JP; Sørensen JB; Andersen PK; Poulsen HE
    Ann Oncol; 2009 Oct; 20(10):1660-6. PubMed ID: 19465420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The maternal homocysteine pathway is influenced by riboflavin intake and MTHFR polymorphisms without affecting the risk of orofacial clefts in the offspring.
    Vujkovic M; Steegers EA; van Meurs J; Yazdanpanah N; van Rooij IA; Uitterlinden AG; Steegers-Theunissen RP
    Eur J Clin Nutr; 2010 Mar; 64(3):266-73. PubMed ID: 19935819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The roles of methylenetetrahydrofolate reductase 677C>T and 1298A>C polymorphisms in moyamoya disease patients.
    Park YS; Jeon YJ; Kim HS; Han IB; Choi JU; Kim DS; Kim NK
    Childs Nerv Syst; 2014 Oct; 30(10):1687-95. PubMed ID: 25098357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case-control study of methylenetetrahydrofolate reductase polymorphisms in cervical carcinogenesis.
    Rao GG; Kurien A; Gossett D; Griffith WF; Coleman RL; Muller CY
    Gynecol Oncol; 2006 May; 101(2):250-4. PubMed ID: 16297972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Candidate gene study of genetic thrombophilic polymorphisms in pre-eclampsia and recurrent pregnancy loss in Sinhalese women.
    Dissanayake VH; Sirisena ND; Weerasekera LY; Gammulla CG; Seneviratne HR; Jayasekara RW
    J Obstet Gynaecol Res; 2012 Sep; 38(9):1168-76. PubMed ID: 22540831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants.
    D'Angelo V; Ramaglia M; Iannotta A; Crisci S; Indolfi P; Francese M; Affinita MC; Pecoraro G; Napolitano A; Fusco C; Oreste M; Indolfi C; Casale F
    Cancer Chemother Pharmacol; 2011 Nov; 68(5):1339-46. PubMed ID: 21590445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Common Methylenetetrahydrofolate Reductase Polymorphisms (A1298C & C677T) in Ectopic Trophoblasts and Methotrexate Treatment Failure in Tubal Pregnancies.
    Zafer E; Kahraman Cetin N; Turan OD; Kardelen E; Kurt Omurlu I; Yuksel H
    Ginekol Pol; 2018; 89(10):536-540. PubMed ID: 30393840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimalization of the clinical pharmacogenetic model to predict methotrexate treatment response: the influence of the number of haplotypes of MTHFR 1298A-677C alleles on probability to respond.
    Kooloos WM; Wessels JA; van der Kooij SM; Allaart CF; Huizinga TW; Guchelaar HJ
    Ann Rheum Dis; 2009 Aug; 68(8):1371. PubMed ID: 19605746
    [No Abstract]   [Full Text] [Related]  

  • 36. Analysis of MTHFR 1298A>C in addition to MTHFR 677C>T polymorphism as a risk factor for neural tube defects in the Turkish population.
    Boduroğlu K; Alanay Y; Alikaşifoğlu M; Aktaş D; Tunçbilek E
    Turk J Pediatr; 2005; 47(4):327-33. PubMed ID: 16363341
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Srisuttayasathien M; Areepium N; Lertkhachonsuk R
    Per Med; 2021 Mar; 18(2):107-114. PubMed ID: 33565324
    [No Abstract]   [Full Text] [Related]  

  • 38. Common polymorphisms in methylenetetrahydrofolate reductase (MTHFR): relationships with plasma homocysteine concentrations and cognitive status in elderly northern italian subjects.
    Ravaglia G; Forti P; Maioli F; Scali RC; Arnone G; Talerico T; Pantieri T; Nativio V; Mantovani V; Bianchin M
    Arch Gerontol Geriatr Suppl; 2004; (9):339-48. PubMed ID: 15207432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered expression of methylenetetrahydrofolate reductase modifies response to methotrexate in mice.
    Celtikci B; Leclerc D; Lawrance AK; Deng L; Friedman HC; Krupenko NI; Krupenko SA; Melnyk S; James SJ; Peterson AC; Rozen R
    Pharmacogenet Genomics; 2008 Jul; 18(7):577-89. PubMed ID: 18551038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylenetetrahydrofolate reductase gene polymorphisms and the risk of colorectal carcinoma in a sample of Egyptian individuals.
    El Awady MK; Karim AM; Hanna LS; El Husseiny LA; El Sahar M; Menem HA; Meguid NA
    Cancer Biomark; 2009; 5(6):233-40. PubMed ID: 20037199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.